U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07802210) titled 'Effectiveness of Innovative Educational Methods in Empowering Children With Sickle Cell Disease' on Aug. 29.
Brief Summary: Sickle-cell disease (SCD) is a genetic disorder that affects hemoglobin, the molecule in red blood cells responsible for carrying oxygen. The disease causes red blood cells to become rigid and sickle-shaped, leading to blockages in blood flow and subsequent pain and organ damage (World Health Organization (WHO),2025).
Patients with sickle cell disease suffer from various complications of the disease during their lifetime, including anemia, sickle cell crises, acute chest syndrome, stroke, renal failure, retina...